HomeCompareKAHTY vs MRK

KAHTY vs MRK: Dividend Comparison 2026

KAHTY yields 105.26% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KAHTY wins by $4.76M in total portfolio value
10 years
KAHTY
KAHTY
● Live price
105.26%
Share price
$1.90
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.82M
Annual income
$1,680,113.32
Full KAHTY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KAHTY vs MRK

📍 KAHTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKAHTYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KAHTY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KAHTY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KAHTY
Annual income on $10K today (after 15% tax)
$8,947.37/yr
After 10yr DRIP, annual income (after tax)
$1,428,096.32/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KAHTY beats the other by $1,419,767.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KAHTY + MRK for your $10,000?

KAHTY: 50%MRK: 50%
100% MRK50/50100% KAHTY
Portfolio after 10yr
$2.44M
Annual income
$844,955.73/yr
Blended yield
34.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KAHTY
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KAHTY buys
0
MRK buys
0
No recent congressional trades found for KAHTY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKAHTYMRK
Forward yield105.26%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4.82M$56.8K
Annual income after 10y$1,680,113.32$9,798.13
Total dividends collected$4.33M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KAHTY vs MRK ($10,000, DRIP)

YearKAHTY PortfolioKAHTY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$21,226$10,526.32$11,206$366.19+$10.0KKAHTY
2$43,594$20,881.77$12,650$502.35+$30.9KKAHTY
3$86,726$40,080.65$14,407$694.19+$72.3KKAHTY
4$167,317$74,520.40$16,585$967.82+$150.7KKAHTY
5$313,393$134,363.82$19,342$1,363.89+$294.1KKAHTY
6$570,536$235,205.45$22,913$1,947.19+$547.6KKAHTY
7$1,010,656$400,181.57$27,662$2,823.89+$983.0KKAHTY
8$1,743,912$662,511.02$34,159$4,173.35+$1.71MKAHTY
9$2,934,379$1,068,392.54$43,337$6,308.80+$2.89MKAHTY
10$4,819,899$1,680,113.32$56,776$9,798.13+$4.76MKAHTY

KAHTY vs MRK: Complete Analysis 2026

KAHTYStock

Kahoot! ASA operates a game-based learning platform in the United States, Canada, Europe, the Asia Pacific, the Latin America and the Caribbean, Africa, the Middle East, and India. The company's platforms help to create, share, and host learning sessions. It offers Kahoot! Learning platform for learning and engagement services; employee engagement and learning platforms, such as Actimo and Motimate; Drops, a language learning app for visuals and play; Kahoot! DragonBox app for math learning; and Kahoot! Poio Read app, which empowers children to learn to read through play. The company also provides Kahoot! Academy, a knowledge platform, online community, and marketplace, which allows educators and publishers to join and create learning communities, as well as provides parents and learners with access to learning content from the educators; Kahoot! 360 Spirit, a collaborative platform for organizations that seek to connect teams and individuals; Kahoot! EDU support program, a site license for schools and districts; and Whiteboard.fi, an online whiteboard that provides learning tools for educators, teachers, and classrooms. In addition, it offers Kahoot! Zoom App platform for engagement and learning to virtual meetings and events; and Clever, a single sign-on digital learning platform for teachers and students. The company has approximately 2 billion participating players in approximately 200 countries. Kahoot! ASA was founded in 2012 and is headquartered in Oslo, Norway.

Full KAHTY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KAHTY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KAHTY vs SCHDKAHTY vs JEPIKAHTY vs OKAHTY vs KOKAHTY vs MAINKAHTY vs JNJKAHTY vs ABBVKAHTY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.